← All companies

ZOMD

Zomedica Corp.

ZOMDF OTC Pharmaceutical Preparations EDGAR ↗

$0.09

+0.00 +1.14%

Key statistics

from XBRL data in SEC filings

Market cap

$87.2M

Revenue (TTM)

$34.3M

Net income (TTM)

-$22.6M

EPS (TTM)

$-0.01

P/E ratio

—

Dividend yield

—

Free cash flow

-$18.2M

Cash

$9.37M

Total assets

$122M

Gross margin

66.3%

52-week range

$0.04 – $0.16

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Shareholder vote results Jun 11, 2026 8-K Results of operations (earnings release) May 6, 2026 10-Q Quarter ended 2026-03-31 May 6, 2026 8-K Results of operations (earnings release) Mar 16, 2026 10-K Fiscal year ended 2025-12-31 Mar 16, 2026 8-K Results of operations (earnings release) Nov 4, 2025 10-Q Quarter ended 2025-09-30 Nov 4, 2025 8-K Results of operations (earnings release) Aug 6, 2025 10-Q Quarter ended 2025-06-30 Aug 6, 2025 8-K Shareholder vote results Jun 11, 2025 8-K Results of operations (earnings release) May 15, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Director or officer change Apr 30, 2025 8-K Results of operations (earnings release) Mar 14, 2025 10-K Fiscal year ended 2024-12-31 Mar 13, 2025 8-K Delisting notice or listing-rule failure Mar 5, 2025 8-K Director or officer change Dec 19, 2024 8-K Entered a material agreement Nov 19, 2024 8-K Results of operations (earnings release) Nov 8, 2024 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release) Aug 14, 2024 8-K Director or officer change Aug 14, 2024 10-Q Quarter ended 2024-06-30 Aug 14, 2024 8-K Shareholder vote results Jun 7, 2024 8-K Results of operations (earnings release) May 9, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Results of operations (earnings release) Apr 4, 2024 10-K Fiscal year ended 2023-12-31 Apr 1, 2024 8-K Delisting notice or listing-rule failure Mar 15, 2024 8-K Shareholder vote results Feb 29, 2024 8-K Results of operations (earnings release) Nov 13, 2023 10-Q Quarter ended 2023-09-30 Nov 13, 2023 8-K Entered a material agreement; Terminated a material agreement Oct 10, 2023 8-K Delisting notice or listing-rule failure Sep 14, 2023 8-K Entered a material agreement; Completed an acquisition or disposition Sep 6, 2023 8-K Results of operations (earnings release) Aug 10, 2023 10-Q Quarter ended 2023-06-30 Aug 10, 2023 8-K Shareholder vote results Jun 14, 2023 8-K Results of operations (earnings release) May 11, 2023 10-Q Quarter ended 2023-03-31 May 11, 2023